# The Effects of Acetylcysteine on Alleviating Damage of Oxidative Stress in Hemodialysis Patients

> **NCT00247507** · PHASE4 · UNKNOWN · sponsor: **Far Eastern Memorial Hospital**

## Conditions studied

- Anemia
- Atherosclerosis
- End-Stage Renal Disease
- Oxidative Stress
- Pro-Inflammation

## Interventions

- **DRUG:** acetylcysteine

## Key facts

- **NCT ID:** NCT00247507
- **Lead sponsor:** Far Eastern Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-09
- **Primary completion:** —
- **Final completion:** 2005-12
- **Target enrollment:** — (—)
- **Last updated:** 2006-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00247507

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00247507, "The Effects of Acetylcysteine on Alleviating Damage of Oxidative Stress in Hemodialysis Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00247507. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*